News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Gary Reuther: SHP2 may be a therapeutic target for patients with MPNs
Photo taken from healthcheckup.com
Jul 28, 2024, 07:14

Gary Reuther: SHP2 may be a therapeutic target for patients with MPNs

Gary Reuther, Professor at Moffitt Cancer Center, shared on X:

“I am excited that our work, led by Garima Pandey, showing SHP2 may be a therapeutic target for patients with myeloproliferative neoplasms (MPNs) is officially published in American Journal of Hematology.

‘SHP2 inhibition displays efficacy as a monotherapy and in combination with JAK2 inhibition in preclinical models of myeloproliferative neoplasms‘

Authors: Garima Pandey, Lucia Mazzacurati, Tegan M. Rowsell, Nathan P. Horvat, Narmin E. Amin, Guolin Zhang, Afua A. Akuffo, Christelle M. Colin-Leitzinger, Eric B. Haura, Andrew T. Kuykendall, Ling Zhang, Pearlie K. Epling-Burnette, Gary W. Reuther.”

Gary Reuther

Source: Gary Reuther/X

Afua A. Akuffo American Journal of Hematology Andrew T. Kuykendall cancer Christelle M. Colin-Leitzinger Eric B. Haura Garima Pandey Gary Reuther Gary W. Reuther Guolin Zhang Ling Zhang Lucia Mazzacurati myeloproliferative neoplasms Narmin E. Amin Nathan P. Horvat OncoDaily Oncology Pearlie K. Epling-Burnette Tegan M. Rowsell
Special Coverage
Blog
Jun 11, 2025, 17:19
Register for Webinar on Medical Cannabis in Oncology Nursing on June 12 - Society for Integrative Oncology
Blog
Jun 11, 2025, 17:07
Donate Today and Fund the Science That Changes Lives - Ovarian Cancer Research Foundation
Blog
Jun 11, 2025, 16:49
Daniel Flora: From Stage IV Cancer to Remission - Clinical Trials Made This Possible
Blog
Jun 11, 2025, 16:36
Ido Didi Fabian: Join ISOO Virtual 2025 to Explore Disparities and Opportunities in Eye Cancer Care
Insight
Jun 11, 2025, 16:12
Immunotherapy Plus Chemotherapy Before Surgery Improves Long-Term Survival in NSCLC - Johns Hopkins Medicine International
Insight
Jun 11, 2025, 15:15
St. Jude Children’s Research Hospital Highlighted Advances in Pediatric Cancer Immunotherapy Through Translational Cell Therapy Program
Blog
Jun 11, 2025, 14:56
Carolina Reduzzi: The "Cancer in a Drop" from the ISLB is Back With AACR 2025 Highlights
Blog
Jun 11, 2025, 14:40
Delighted to Announce Our Ground-Breaking €10M PEACEPLUS Digital ONEHEALTH Programme - Mark Lawler
Blog
Jun 11, 2025, 14:27
New White Paper: Why CancerX is the Future of Collaborative Cancer Care Innovation?
Blog
Jun 11, 2025, 14:15
World Child Cancer Partners With Local Health Teams to Bring Life-saving Care to Children and Cancel Child Cancer
Career
Jun 11, 2025, 14:03
Penn State Health Children's Hospital is Recruiting a Leader for Cellular Therapies and BMT Division
Insight
Jun 11, 2025, 13:51
Naveen Pemmaraju Shared 2025 Leukemia Review on Epigenetic Therapies in Myeloid Cancers